Emmanouil E. Kellis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Emmanouil E. Kellis has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Alexandros G. Mathioudakis
Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
1 shared publication - Apostolos Beloukas
Department of Biomedical Sciences, School of Health Sciences, University of West Attica, 12243 Athens, Greece
1 shared publication - Christine Kottaridi
Laboratory of General Microbiology, Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
1 shared publication - Ioannis Karakasiliotis
Laboratory of Biology, School of Medicine, Democritus University of Thrace, 68100 Alexandroupolis, Greece
1 shared publication - Ioannis Mitroulis
Translational Research and Laboratory Medicine Unit, First Department of Internal Medicine, University Hospital of Alexandroupolis, Democritus University of Thrace, 68100 Alexandroupolis, Greece
1 shared publication - Konstantinos Konstantinidis
Laboratory of Biology, Department of Medicine, Democritus University of Thrace, Dragana, 68100 Alexandroupolis, Greece
1 shared publication
Latest Publications
- Open Access
- 8 September 2022
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 7 (9) , 236
West Nile Disease Symptoms and Comorbidities: A Systematic Review and Analysis of Cases
West Nile virus (WNV) is a mosquito-borne flavivirus that has emerged as a major cause of viral encephalitis and meningitis, rarely leading to death. Several risk factors have been discussed in the past concerning the severity of the disease, while few reports have focused on precipitating conditions that determine of WNV-related death. Studies on cohorts of patients suffering of West Nile disease (WND) usually encompass low numbers of deceased patients as a result of the rarity of the event. In this systematic review and critical analysis of 428 published case studies and case series, we sought to evaluate and highlight critical parameters of WND-related death. We summarized the symptoms, comorbidities, and treatment strategies related to WND in all published cases of patients that included clinical features. Symptoms such as altered mental status and renal problems presented increased incidence among deceased patients, while these patients presented increased cerebrospinal fluid (CSF) glucose. Our analysis also highlights underestimated comorbidities such as pulmonary disease to act as precipitating conditions in WND, as they were significantly increased amongst deceased patients. CSF glucose and the role of pulmonary diseases need to be revaluated either retrospectively or prospectively in WND patient cohorts, as they may be linked to increased mortality risk.
- 8 September 2022
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 7 (9) , 236
Open AccessWest Nile Disease Symptoms and Comorbidities: A Systematic Review and Analysis of Cases
West Nile virus (WNV) is a mosquito-borne flavivirus that has emerged as a major cause of viral encephalitis and meningitis, rarely leading to death. Several risk factors have been discussed in the past concerning the severity of the disease, while few reports have focused on precipitating conditions that determine of WNV-related death. Studies on cohorts of patients suffering of West Nile disease (WND) usually encompass low numbers of deceased patients as a result of the rarity of the event. In this systematic review and critical analysis of 428 published case studies and case series, we sought to evaluate and highlight critical parameters of WND-related death. We summarized the symptoms, comorbidities, and treatment strategies related to WND in all published cases of patients that included clinical features. Symptoms such as altered mental status and renal problems presented increased incidence among deceased patients, while these patients presented increased cerebrospinal fluid (CSF) glucose. Our analysis also highlights underestimated comorbidities such as pulmonary disease to act as precipitating conditions in WND, as they were significantly increased amongst deceased patients. CSF glucose and the role of pulmonary diseases need to be revaluated either retrospectively or prospectively in WND patient cohorts, as they may be linked to increased mortality risk.